European Economic Area
Northern IrelandBiocidal Products Regulation (BPR)
Commission Accepts Hungary’s Refusal Of URAGAN D2 Mutual Recognition
The Commission accepts Hungary’s refusal of URAGAN D2 mutual recognition; the decision does not impose an EU-wide hydrogen-cyanide ban.
Published in September 2024. Dates, deadlines and stages may have changed since.
Dr Steven Brennan
1 min readAI-drafted, expert reviewed
Correction, 20 October 2026. This article has been revised to clarify the territorial scope and legal effect of the decision.
The European Commission accepted Hungary's proposed refusal of mutual recognition for URAGAN D2, a biocidal product containing hydrogen cyanide. Implementing Decision (EU) 2024/2420 was adopted on 13 September 2024 and published on 16 September.
Grounds For The Refusal
The decision concerns the availability of antidotes needed for safe use under the Hungarian arrangements described in its recitals. Article 1 finds Hungary's refusal justified on grounds of protecting human health and life under Article 37(1)(c) of the Biocidal Products Regulation.
The product is identified by Register for Biocidal Products case number BC-JN038446-27.
Scope Of The Decision
Article 2 addresses the decision to Hungary. It concerns refusal of mutual recognition for the identified product, rather than an EU-wide prohibition on hydrogen cyanide or all products containing it.
Official source
eur-lex.europa.euQuestions about this change
Why did the European Commission accept Hungary's refusal of URAGAN D2 mutual recognition?
Decision (EU) 2024/2420 accepts Hungary's refusal of URAGAN D2 mutual recognition because the conditions for safe use could not be met. The required antidotes were not available at fumigation sites under the Hungarian arrangements described in the decision.
Does the URAGAN D2 decision establish an EU-wide ban on hydrogen cyanide?
No. The URAGAN D2 decision concerns Hungary's refusal of mutual recognition for that biocidal product. It does not establish an EU-wide prohibition on hydrogen cyanide.
Dr Steven Brennan
CEO and co-founder of Foresight, and a co-opted member of ECHA's Committee for Socio-economic Analysis. He holds a PhD in chemical engineering.
More from Dr Steven BrennanFind out what this means for your products
Foresight follows changes like this one and shows where they reach your substances, products and markets.
Great Britain
European Economic Area
ECHA Unveils New Guidance To Shield Bees From Biocidal Threats
European Economic Area
IPBC Alternatives Face Challenges In Meeting EU Biocidal Regulations
Join 3,500+ professionals staying ahead
Foresight Weekly brings the week's regulatory changes across chemicals, product safety, sustainability, ESG and EHS into one email.
Read by professionals at
